These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1345392)

  • 21. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The case for wide local excision and regional node dissection for high-risk cutaneous melanoma.
    Karakousis CP
    Curr Opin Gen Surg; 1993; ():303-9. PubMed ID: 7583999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiology and prognostic factors in cutaneous malignant melanoma].
    Milo Y; Tamir G; Robinpour M; Sulkes J; Rotem A; Schachter J; Hauben DJ
    Harefuah; 1995 Jun; 128(12):745-51, 824. PubMed ID: 7557679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous malignant melanoma of the head and neck.
    Fisher SR
    Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumor biology of melanoma nodal metastases.
    Miliotes G; Albertini J; Berman C; Heller R; Messina J; Glass F; Cruse W; Rapaport D; Puleo C; Fenske N; Petsoglou C; Deconti R; Lyman G; Reintgen D
    Am Surg; 1996 Jan; 62(1):81-8. PubMed ID: 8540654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.
    Thomas JM; Clark MA
    Eur J Surg Oncol; 2004 Aug; 30(6):686-91. PubMed ID: 15256245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elective radiation therapy for high-risk malignant melanomas.
    Cooper JS; Chang WS; Oratz R; Shapiro RL; Roses DF
    Cancer J; 2001; 7(6):498-502. PubMed ID: 11769862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Time periods of the occurrence of local recurrences and the late results of the treatment of skin melanomas following surgical excision of the primary tumor].
    Anisimov VV
    Vopr Onkol; 1983; 29(5):25-8. PubMed ID: 6858061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
    Hughes TM; A'Hern RP; Thomas JM
    Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
    van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
    Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
    Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
    Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence of cutaneous malignant melanoma after more than 20 years.
    Bredgaard R; Lock-Andersen J
    J Plast Surg Hand Surg; 2011 Apr; 45(2):113-6. PubMed ID: 21504283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term follow-up in cutaneous malignant melanoma: the relationship of maximal tumour thickness to disease free survival, disease recurrence and death.
    Griffiths RW; Briggs JC
    Br J Plast Surg; 1984 Oct; 37(4):507-13. PubMed ID: 6498389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data on first recurrence after treatment for malignant melanoma in a large patient population.
    Fusi S; Ariyan S; Sternlicht A
    Plast Reconstr Surg; 1993 Jan; 91(1):94-8. PubMed ID: 8416544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I).
    Milton GW; Shaw HM; Farago GA; McCarthy WH
    Br J Surg; 1980 Aug; 67(8):543-6. PubMed ID: 7427045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of thin (< 1.5 mm) malignant melanomas with poor prognosis.
    Park KG; Blessing K; McLaren KM; Watson AC
    Br J Plast Surg; 1993 Oct; 46(7):607-10. PubMed ID: 8252271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas.
    Weiss M; Loprinzi CL; Creagan ET; Dalton RJ; Novotny P; O'Fallon JR
    JAMA; 1995 Dec; 274(21):1703-5. PubMed ID: 7474276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Satellite in transit metastases in rapidly fatal conjunctival melanoma: implications for angiotropism and extravascular migratory metastasis (description of a murine model for conjunctival melanoma).
    Barnhill RL; Lemaitre S; Lévy-Gabrielle C; Rodrigues M; Desjardins L; Dendale R; Vincent-Salomon A; Roman-Roman S; Lugassy C; Cassoux N
    Pathology; 2016 Feb; 48(2):166-76. PubMed ID: 27020389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.